Profile data is unavailable for this security.
About the company
Visiomed Group SA is a France-based company. The Company is primarily engaged in the design, manufacture and marketing of medical electronics. It develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The Company's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The Company serves pharmacies, health professionals, hospitals, clinics and retirement homes. It also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.
- Revenue in EUR (TTM)12.04m
- Net income in EUR-3.54m
- Incorporated2009
- Employees73.00
- LocationVisiomed Group SA74 rue BlanchePARIS 75009FranceFRA
- Phone+33 180272990
- Fax+33 144179310
- Websitehttps://www.visiomed-group.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spineguard SA | 5.29m | -3.23m | 11.45m | 24.00 | -- | 1.54 | -- | 2.16 | -0.0899 | -0.0899 | 0.1489 | 0.1569 | 0.4415 | 1.47 | 6.19 | 229,895.20 | -26.94 | -21.36 | -37.72 | -41.38 | 74.38 | 77.29 | -61.01 | -33.68 | 1.76 | -7.56 | 0.3553 | -- | 27.11 | -7.29 | -38.75 | -- | 55.68 | -- |
| Laboratoires Euromedis SA | 49.54m | -5.51m | 13.31m | 194.00 | -- | 0.4772 | -- | 0.2687 | -1.84 | -1.84 | 16.46 | 9.70 | 0.8283 | 3.54 | 4.88 | 255,371.10 | -9.19 | -- | -11.45 | -- | 32.67 | -- | -11.09 | -- | 3.57 | -12.83 | 0.2875 | -- | -51.58 | -- | -362.99 | -- | -- | -- |
| Alpha Mos SA | 6.16m | -3.39m | 14.20m | 48.00 | -- | -- | -- | 2.31 | -0.3105 | -0.3105 | 0.5637 | -0.5066 | 0.8424 | 2.24 | 4.99 | 128,270.80 | -46.70 | -50.01 | -481.38 | -102.49 | 71.27 | 68.37 | -55.43 | -74.15 | 0.4423 | -10.76 | 11.30 | -- | 2.25 | 7.46 | -39.13 | -- | 7.59 | -- |
| Theraclion SA | 1.87m | -4.88m | 16.92m | 30.00 | -- | 2.50 | -- | 9.05 | -0.1362 | -0.1362 | 0.0504 | 0.1481 | 0.1021 | 0.282 | 1.23 | 66,785.00 | -26.65 | -40.08 | -35.36 | -59.96 | 54.21 | 52.19 | -260.94 | -276.13 | 2.50 | -56.17 | 0.2546 | -- | -16.58 | -12.66 | -32.02 | -- | 11.77 | -- |
| Diagnostic Medical Systems SA | 37.53m | 3.02m | 19.92m | 120.00 | 7.16 | 1.10 | 3.67 | 0.5309 | 0.1577 | 0.0283 | 2.17 | 1.03 | 0.7146 | 1.69 | 4.58 | 320,760.70 | 3.97 | -11.14 | 6.98 | -19.52 | 39.49 | 37.79 | 5.55 | -15.54 | 0.8608 | -5.70 | 0.5059 | -- | -4.57 | 5.40 | -44.25 | -- | -- | -- |
| Mauna Kea Technologies SA | 10.90m | -2.17m | 24.27m | 67.00 | -- | -- | 22.56 | 2.23 | -0.0488 | -0.0488 | 0.2449 | -0.3386 | 0.5265 | 2.01 | 6.73 | 194,696.40 | -2.61 | -58.19 | -5.19 | -83.91 | 37.11 | -1.33 | -4.96 | -182.40 | 0.7405 | 29.85 | 2.22 | -- | -2.87 | 2.26 | 16.85 | -- | -27.66 | -- |
| Novacyt SA | 9.20m | -29.56m | 53.06m | 222.00 | -- | 0.4231 | -- | 5.77 | -0.4185 | -0.4198 | 0.1302 | 1.78 | 0.0528 | 1.33 | 0.2622 | 41,424.52 | -16.96 | 17.69 | -20.71 | 23.82 | 43.21 | 62.82 | -321.40 | 23.87 | 4.98 | -79.02 | 0.0036 | 0.00 | -77.28 | 13.49 | -269.46 | -- | -13.46 | -- |
| Visiomed Group SA | 12.04m | -3.54m | 56.46m | 73.00 | -- | 2.47 | -- | 4.69 | -0.0119 | -0.0119 | 0.0406 | 0.0776 | 0.3453 | 1.40 | 6.88 | 174,550.70 | -10.44 | -53.01 | -12.11 | -127.09 | 91.46 | 41.03 | -30.24 | -99.08 | 1.70 | -9.31 | 0.2631 | -- | 101.38 | 6.67 | -18.40 | -- | 52.36 | -- |
| Affluent Medical SAS | 0.00 | -15.02m | 61.15m | 52.00 | -- | 1.46 | -- | -- | -0.6596 | -0.6596 | 0.00 | 1.26 | 0.00 | -- | -- | 0.00 | -23.91 | -23.11 | -27.18 | -26.49 | -- | -- | -- | -- | -- | -10.51 | 0.2905 | -- | -- | -- | -2.75 | -- | -11.10 | -- |
| Carmat SA | 895.00k | -54.36m | 110.68m | 177.00 | -- | -- | -- | 123.66 | -2.25 | -2.25 | 0.0369 | -0.3817 | 0.0123 | 1.58 | 0.2029 | 5,000.00 | -74.73 | -76.92 | -89.51 | -93.77 | -3,232.74 | -- | -6,074.19 | -9,203.39 | 2.81 | -14.25 | 1.18 | -- | -84.52 | -- | 13.24 | -- | -10.97 | -- |
| Bastide Le Confort Medical SA | 523.32m | 6.32m | 113.82m | 3.55k | 21.21 | 1.41 | 1.39 | 0.2175 | 0.7299 | 0.772 | 65.57 | 11.02 | 0.7955 | 5.44 | 6.90 | 147,580.70 | 1.84 | 2.49 | 2.66 | 3.52 | 50.54 | 48.82 | 2.31 | 3.05 | 0.811 | 1.92 | 0.8391 | -- | 8.48 | 11.94 | 11.24 | 17.55 | 6.98 | -- |
| Amplitude Surgical SA | 104.05m | 43.23m | 148.86m | 416.00 | 3.44 | 1.57 | 2.72 | 1.43 | 0.9002 | 0.9002 | 2.17 | 1.97 | 0.3955 | 0.5652 | 8.83 | 244,244.10 | 16.21 | -0.3658 | 19.44 | -0.4267 | 79.41 | 78.30 | 40.98 | -1.08 | 1.21 | 0.4163 | 0.5395 | -- | 14.44 | -0.0271 | 993.58 | -- | 7.11 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Sunny Asset Management SAas of 27 Mar 2024 | 3.60m | 1.22% |
| Meeschaert Asset Management SAas of 14 Sep 2023 | 400.00k | 0.14% |
| NOVACAP Asset Management SAas of 31 Mar 2020 | 2.00 | 0.00% |
| Gestys SAas of 29 Dec 2023 | 0.00 | 0.00% |
